A new covalent organic framework uses boron and phosphorus to make complex connections. This new COF is composed of repeating borophosphonate cubes linked at the vertices. O = red; B = pink; P...
Researchers at the Department of Energy’s Lawrence Berkeley National Laboratory have developed a new separation method that is vastly more efficient than conventional processes, opening the door to faster discovery of new elements, easier nuclear fuel reprocessing, and, most tantalizing, a better way to attain actinium-225, a promising therapeutic isotope for cancer treatment.
A team of researchers, including faculty from Northwestern Engineering and UC Berkeley's College of Chemistry, has expanded the understanding of how virus shells self-assemble, an important step toward developing techniques that use viruses as vehicles to deliver targeted drugs and therapeutics throughout the body.
Frances Arnold admits it will be an emotional moment Friday when, as winner of the 2018 Nobel Prize in Chemistry, she’ll be the featured attraction at UC Berkeley for a Dean’s Dinner and reception at the College of Chemistry.
Zinc-zinc bonds are rare in chemistry. So are linear four-metal compounds. Nevertheless, Trevor D. Lohrey, a member of John Arnold’s group at the University of California, Berkeley, has made the first molecule with a Re-Zn-Zn-Re core. Lohrey used a rhenium(I) salt to reduce ZnCl2 and make a zinc cation to which anionic rhenium compounds coordinated.
With the help of sponges inserted in the bloodstream to absorb excess drugs, doctors and scientists are hoping to prevent the dangerous side effects of toxic chemotherapy agents or even deliver higher doses to knock back tumors, like liver cancer, that don’t respond to more benign treatments.
Sciencedaily.com | DOE/Sandia National Laboratories
The longstanding mystery of soot formation, which combustion scientists have been trying to explain for decades, appears to be finally solved, thanks to research led by scientists at Sandia National Laboratories. This groundbreaking work was published in 'Science' magazine with involvement from scientists at UC Berkeley and Lawrence Berkeley Lab.
Imagine a future where chemists could restructure the morphine molecule to have the opiate pain management value but not the addictive side effect. That is one possible outcome of an exciting new process being reported in Science magazine from the chemistry lab of Richmond Sarpong at UC Berkeley.
Researchers at the Department of Energy’s Lawrence Berkeley National Laboratory have developed a new separation method that is vastly more efficient than conventional processes, opening the door to faster discovery of new elements, easier nuclear fuel reprocessing, and, most tantalizing, a better way to attain actinium-225, a promising therapeutic isotope for cancer treatment.
Frances Arnold admits it will be an emotional moment Friday when, as winner of the 2018 Nobel Prize in Chemistry, she’ll be the featured attraction at UC Berkeley for a Dean’s Dinner and reception at the College of Chemistry.
Zinc-zinc bonds are rare in chemistry. So are linear four-metal compounds. Nevertheless, Trevor D. Lohrey, a member of John Arnold’s group at the University of California, Berkeley, has made the first molecule with a Re-Zn-Zn-Re core. Lohrey used a rhenium(I) salt to reduce ZnCl2 and make a zinc cation to which anionic rhenium compounds coordinated.
With the help of sponges inserted in the bloodstream to absorb excess drugs, doctors and scientists are hoping to prevent the dangerous side effects of toxic chemotherapy agents or even deliver higher doses to knock back tumors, like liver cancer, that don’t respond to more benign treatments.
The longstanding mystery of soot formation, which combustion scientists have been trying to explain for decades, appears to be finally solved, thanks to research led by scientists at Sandia National Laboratories. This groundbreaking work was published in 'Science' magazine with involvement from scientists at UC Berkeley and Lawrence Berkeley Lab.
The research, led by Peidong Yang of Berkeley Lab's Materials Sciences Division
Imagine a future where chemists could restructure the morphine molecule to have the opiate pain management value but not the addictive side effect. That is one possible outcome of an exciting new process being reported in Science magazine from the chemistry lab of Richmond Sarpong at UC Berkeley.